LGR4 is essential for maintaining β-cell homeostasis through suppression of RANK

Joanna Filipowska1, Zelda Cisneros1, Sneha S Varghese1

  • 1Arthur Riggs Diabetes and Metabolism Research Institute, City of Hope, Duarte, CA 91010, USA; Department of Translational Research and Cellular Therapeutics, City of Hope, Duarte, CA 91010, USA.

Molecular Metabolism
|January 9, 2025
PubMed
Abstract

Insights

Leucine-rich repeat-containing G-protein-coupled receptor 4 (LGR4) protects beta-cells from death and promotes their health. LGR4 suppresses Receptor Activator of NFκB (RANK) signaling, crucial for diabetes treatment.

Area of Science:

  • Endocrinology and Metabolism
  • Cell Biology
  • Diabetes Research

Background:

  • Loss of functional beta-cell mass is a primary driver of diabetes.
  • Leucine-rich repeat-containing G-protein-coupled receptor 4 (LGR4) is present in human islets, but its role in beta-cell health is unknown.
  • Receptor Activator of Nuclear Factor Kappa B (NFκB) (RANK) is a known negative regulator of beta-cell health.

Purpose of the Study:

  • To investigate the regulation of Lgr4 in pancreatic islets.
  • To determine the role of LGR4 and its interaction with RANK in beta-cell health.
  • To assess LGR4 function under basal and stress conditions, both in vitro and in vivo.

Main Methods:

  • Evaluated Lgr4 expression in mouse and human islets under various stress conditions (cytokines, high-fat diet, db/db mice, aging).
  • Utilized in vitro Lgr4 loss-of-function and gain-of-function studies in primary rodent and human beta-cells.
  • Generated beta-cell-specific conditional knockout mice (Lgr4cko and Lgr4/Rank dko) to assess in vivo roles.

Main Results:

  • Lgr4 expression decreased under stress; Lgr4 knockdown impaired beta-cell proliferation and survival, while overexpression protected against cell death.
  • LGR4 suppresses RANK-TRAF6 interaction, inhibiting NFκB activation and protecting beta-cells.
  • Lgr4cko mice showed increased beta-cell death and impaired proliferation/maturation (females), with rescued phenotypes in dko mice and impaired homeostasis in aged Lgr4cko mice.

Conclusions:

  • LGR4 acts as a novel positive regulator of beta-cell health under both basal and stress conditions.
  • LGR4 exerts its protective effects by antagonizing the detrimental actions of RANK.
  • These findings highlight LGR4 as a potential therapeutic target for diabetes.

Related Concept Videos

Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
3.1K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.1K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
295
Feedback Loops01:01

Feedback Loops

In most cases, excessive hormone production is prevented by negative feedback—a loop that starts with a stimulus inducing the release of a particular substance, like a hormone, to maintain a certain level before triggering a signal that results in a decrease in further release of the hormone.
55.9K
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
1.4K
Cells and Secretions of the Pancreas01:16

Cells and Secretions of the Pancreas

The pancreas, a vital organ within the abdominal cavity, plays dual roles in the digestive and endocrine systems, collaborating with exocrine and endocrine cells to maintain optimal digestion and blood sugar levels.
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
2.0K